128 related articles for article (PubMed ID: 20180612)
1. Cethromycin: a promising new ketolide antibiotic for respiratory infections.
Rafie S; MacDougall C; James CL
Pharmacotherapy; 2010 Mar; 30(3):290-303. PubMed ID: 20180612
[TBL] [Abstract][Full Text] [Related]
2. Cethromycin: a new ketolide antibiotic.
Mansour H; Chahine EB; Karaoui LR; El-Lababidi RM
Ann Pharmacother; 2013 Mar; 47(3):368-79. PubMed ID: 23463743
[TBL] [Abstract][Full Text] [Related]
3. Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections.
Hammerschlag MR; Sharma R
Expert Opin Investig Drugs; 2008 Mar; 17(3):387-400. PubMed ID: 18321237
[TBL] [Abstract][Full Text] [Related]
4. Tigecycline: an investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms.
Garrison MW; Neumiller JJ; Setter SM
Clin Ther; 2005 Jan; 27(1):12-22. PubMed ID: 15763603
[TBL] [Abstract][Full Text] [Related]
5. The evolution of antimicrobial agents used for the management of CARTIs: a focus on a new class of antimicrobials--the ketolides.
Sbarbaro JA
Am J Manag Care; 2004 Oct; 10(12 Suppl):S389-99. PubMed ID: 15603248
[No Abstract] [Full Text] [Related]
6. Dalbavancin: a new option for the treatment of gram-positive infections.
Lin SW; Carver PL; DePestel DD
Ann Pharmacother; 2006 Mar; 40(3):449-60. PubMed ID: 16507624
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
[TBL] [Abstract][Full Text] [Related]
8. Faropenem medoxomil.
Gettig JP; Crank CW; Philbrick AH
Ann Pharmacother; 2008 Jan; 42(1):80-90. PubMed ID: 18094341
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic resistance in community-acquired respiratory tract infections: current issues.
Spach DH; Black D
Ann Allergy Asthma Immunol; 1998 Oct; 81(4):293-302; quiz 302-3. PubMed ID: 9809491
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of macrolide resistance in community-acquired respiratory tract infections.
Hoban DJ; Zhanel GG
Expert Rev Anti Infect Ther; 2006 Dec; 4(6):973-80. PubMed ID: 17181414
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
12. Ribosome affinity and the prolonged molecular postantibiotic effect of cethromycin (ABT-773) in Haemophilus influenzae.
Cao Z; Zhong P; Ruan X; Merta P; Capobianco JO; Flamm RK; Nilius AM
Int J Antimicrob Agents; 2004 Oct; 24(4):362-8. PubMed ID: 15380262
[TBL] [Abstract][Full Text] [Related]
13. Ketolides: a new class of antibacterial agents for treatment of community-acquired respiratory tract infections in a primary care setting.
Clark JP; Langston E
Mayo Clin Proc; 2003 Sep; 78(9):1113-24. PubMed ID: 12962166
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of ertapenem: review of recent studies.
Wexler HM
J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii11-21. PubMed ID: 15150179
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of the investigational ketolide cethromycin against macrolide- and penicillin-resistant Streptococcus pneumoniae: review of the 1998 to 2006 Canadian Respiratory Organism Susceptibility Study (CROSS).
Wierzbowski AK; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2009 Mar; 63(3):620-2. PubMed ID: 19151038
[No Abstract] [Full Text] [Related]
16. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
[TBL] [Abstract][Full Text] [Related]
17. Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
Falagas ME; Kasiakou SK
Infection; 2007 Feb; 35(1):3-10. PubMed ID: 17297582
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cethromycin, a new ketolide, against Streptococcus pneumoniae susceptible or resistant to erythromycin in a murine pneumonia model.
Azoulay-Dupuis E; Mohler J; Bédos JP; Barau C; Fantin B
Antimicrob Agents Chemother; 2006 Sep; 50(9):3033-8. PubMed ID: 16940099
[TBL] [Abstract][Full Text] [Related]
19. Telithromycin: the first ketolide antimicrobial.
Nguyen M; Chung EP
Clin Ther; 2005 Aug; 27(8):1144-63. PubMed ID: 16199242
[TBL] [Abstract][Full Text] [Related]
20. Meeting the challenge of antibiotic resistance: The PROTEKT US study.
Stratton CW
Postgrad Med; 2002 Sep; 112(3 Suppl):7-11. PubMed ID: 19667589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
